Rainbow Children's Medicare Board Meeting Scheduled for May 23, 2026 to Approve Q4 FY26 Results and Consider Final Dividend
Rainbow Children's Medicare Limited has scheduled a Board of Directors meeting for Saturday, May 23, 2026, to consider and approve the Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year ended March 31, 2026. The Board will also deliberate on recommending a Final Dividend, if any, on equity shares for FY26. In line with SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for the company's securities remains closed and will reopen 48 hours after the financial results are declared. The intimation was filed under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Rainbow Children's Medicare Limited has informed the stock exchanges of an upcoming Board of Directors meeting, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is scheduled to be held on Saturday, May 23, 2026, and will take up key financial and corporate agenda items for the concluded fiscal year.
Board Meeting Agenda
The Board meeting has been convened to address the following key matters:
- Approval of Audited Financial Results: The Board will consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended March 31, 2026.
- Final Dividend Recommendation: The Board will also consider recommending a Final Dividend, if any, on the Equity Shares of the Company for the Financial Year ended March 31, 2026.
The following table summarises the key details of the scheduled board meeting:
| Parameter: | Details |
|---|---|
| Meeting Date: | Saturday, May 23, 2026 |
| Results Period: | Quarter and Financial Year ended March 31, 2026 |
| Results Type: | Audited Standalone & Consolidated |
| Dividend Consideration: | Final Dividend on Equity Shares, if any, for FY ended March 31, 2026 |
| Regulatory Reference: | Regulation 29 of SEBI (LODR) Regulations, 2015 |
Trading Window Closure
In continuation of the company's letter dated March 25, 2026, and in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code for Prevention of Insider Trading, the Trading Window for dealing in the securities of Rainbow Children's Medicare Limited is currently closed. The Trading Window shall reopen 48 hours after the declaration of the aforementioned financial results.
The intimation was signed by Shreya Mitra, Company Secretary and Compliance Officer, on May 15, 2026. The company's registered office is located at 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad, Telangana - 500034.
Historical Stock Returns for Rainbow Childrens Medicare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.37% | +1.03% | +4.34% | +1.50% | -0.36% | +199.87% |
How might Rainbow Children's Medicare's FY2026 revenue and profitability compare to the previous fiscal year, given the expansion of pediatric healthcare infrastructure across India?
Will the Board's dividend decision signal a shift in Rainbow Children's Medicare's capital allocation strategy between shareholder returns and reinvestment for capacity expansion?
How could Rainbow Children's Medicare's FY2026 financial results influence investor sentiment and stock performance relative to other listed healthcare and hospital sector peers?


































